Ridker, P.M., Everett, B.M., Thuren, T. et al. (2017) Anti– inflammatory therapy with canakinumab for atherosclerotic disease, N Engl J Med 377: 1119–1131 doi:10.1056/ NEJMoa1707914

Oswald, L., Grosser, S., Smith, D. M. and Käs, J. A. (2017) Jamming transitions in cancer, Journal of Physics D 50: 483001 doi:10.1088/1361–6463/aa8e83

Fojo, T. (2018) Desperation oncology, Seminars in Oncology 45: 105–106 doi:10.1053/j.seminoncol.2018.08.001

Kaiser, J. (2019) New drugs that unleash the immune system on cancers may backfire, fueling tumor growth, Science (published online 28 March 2019) doi:10.1126/science. aax5021

Champiat, S., Dercle, L., Ammari, S. et al.(2017) Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1, Clin Cancer Res 23: 1920–1928 doi:10.1158/1078–0432.CCR-16–1741

Obradovi, M.M.S., Hamelin, B., Manevski, N. et al. (2019) Glucocorticoids promote breast cancer metastasis, Nature 567: 540–544 doi:10.1038/s41586–019–1019–4

Greaves, M. (2018) A causal mechanism for childhood acute lymphoblastic leukaemia, Nat Rev Cancer 18: 471–484 doi:10.1038/s41568–018–0015–6

Gopalakrishnan, V., Helmink, B. A., Spencer, C. N. et al. (2018). The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy, Cancer Cell 33: 570–580 doi:10.1016/j.ccell.2018.03.015

Alexander, J., Wilson, I., Teare, J. et al. (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity, Nat Rev Gastroenterol Hepatol 14: 356–365 doi:10.1038/ nrgastro.2017.20

Richards, S.E. (2019) How the microbiome could be the key to new cancer treatments, Smithsonian Magazine (published online 8 March 2019) bit.ly/37GFLii